Sweden's SOBI to buy Arthrosi Therapeutics for $1.5 billion

Swedish Orphan Biovitrum AB (publ)

13/12/2025 16:14

Dec 13 (Reuters) - Drugmaker Swedish Orphan Biovitrum SOBIV.ST said on Saturday it had entered into an agreement to acquire biotechnology company Arthrosi Therapeutics for $1.5 billion.

Sobi will pay $950 million upfront in cash to acquire Arthrosi, and $550 million in cash in clinical, regulatory and sales milestones.

 (Reporting by Gnaneshwar Rajan in Bengaluru, Editing by Timothy Heritage)

 ((Gnaneshwar.Rajan@thomsonreuters.com;))